Community Blood Center
$72.5K 65 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Merete Technologies, Inc
Merete Technologies, Inc reported $72,094.27 across General Payments, Research, and Ownership to 29 physicians and teaching hospitals across 29 transactions.
- $72.1K Below-median payer
- All-tracks total
- 29 Below-median volume
- Transactions
- 29 Below-median reach
- Recipients
- +$15.1K
- General Payments vs PY2023
Merete Technologies, Inc reported $72,094.27 across all CMS Open Payments tracks (General + Research + Ownership) to 29 physicians and teaching hospitals in Program Year 2024 - ranking #1265 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $72,094.27, averaging $2.5K per recipient.
Merete Technologies, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
14/100
Total payments
F
11/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer merete-technologies-inc Merete Technologies, Inc
$72.1K · #1265/1,925 · 0.0% industry · PY2024
- TOT $72.1K
- RANK #1265
- SHARE 0.0%
- TXN 29
- RCP 29
- CAT 2
- GEN $72.1K
- ΔGEN +$15.1K
- TOP1 46.3%
- PY 2024
Volume peers
Nearest volume peer: Community Blood Center ($72.5K)
Merete Technologies, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Merete Technologies, Inc's CMS-reported General Payments increased by $15.1K (+26.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: MERETE TECHNOLOGIES, INCPY2023: MERETE TECHNOLOGIES, INCPY2024: Merete Technologies, Inc. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $57,013.51
- PY2024
- $72,094.27
What the Data Shows for Merete Technologies, Inc
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Merete Technologies, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
16 transactions worth $44.6K make "Royalty or License" the top general-payment category in the 2-category breakdown below, 61.9% of General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
Merete Technologies, Inc made 2 types of general payments. "Royalty or License" is the largest category at $44.6K, 61.9% of General Payments.
How Merete Technologies, Inc divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $44.6K | 16 | 61.9% |
| Consulting Fee | $27.5K | 13 | 38.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $66,094.27 (91.7%) of $72,094.27 in this company's General Payments records across 8 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Merete Technologies, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Joseph Benevenia
$33,413.02 across 4 reported transactions
- 2
William Bush
$21,371.97 across 9 reported transactions
- 3
Thomas Nordquist
$4,000.00 across 2 reported transactions
- 4
Douglas Pacaccio
$3,996.72 across 4 reported transactions
- 5
Steven Neufeld
$3,312.56 across 4 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Merete Technologies, Inc ranks #1265 of 1,925 by total payments (bottom 34% by spend) but is notably more concentrated than that alone would suggest -- #552 of 1,838 by HHI (top 30% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Atlas Ocular, Inc : $35.4K total payments, HHI 3194
- HF Acquisition Co. LLC : $46.1K total payments, HHI 3193
- Okami Medical, Inc. : $92.0K total payments, HHI 3180
- Levita Magnetics International Corp. : $2.4K total payments, HHI 3174
- Perspectum Diagnostics Ltd : $1.1M total payments, HHI 3165
- Veru Inc. : $149.5K total payments, HHI 3151
- Merete Technologies, Inc (this company) : $72.1K total payments, HHI 3135
- Vifor (International) Ltd. : $132.0K total payments, HHI 3112
- Asklepios Biopharmaceutical Inc. : $7.6M total payments, HHI 3111
- Lumenis BE LTD : $35.5K total payments, HHI 3093
- Republic Spine : $567.3K total payments, HHI 3085
- Cook Research Incorporated : $288.6K total payments, HHI 3073
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Merete Technologies, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Merete Technologies, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Merete Technologies, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Baylis Medical Technologies Inc.
$71.7K 168 recipients
Compare payment profiles
Institut de Recherches Internationales Servier
$71.4K 0 recipients
Compare payment profiles
KOELIS Inc.
$73.0K 234 recipients
Compare payment profiles
Omniscient Neurotechnology America Ltd
$73.2K 72 recipients
Compare payment profiles
Silony Medical Corp.
$70.7K 9 recipients
Compare payment profiles
Put this to use
Merete Technologies, Inc ranks #1265 of 1,925 by all-tracks total payments, led by "Royalty or License".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Royalty or License" spend across every manufacturer, not just Merete Technologies, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.